129
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Reversible Neuropsychiatric Disturbances Caused by Nitrous Oxide Toxicity: Clinical, Imaging and Electrophysiological Profiles of 21 Patients with 6–12 Months Follow-up

, , , , , , , , , & ORCID Icon show all
Pages 2817-2825 | Published online: 23 Nov 2020

References

  • Weimann J. Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol. 2003;17(1):47–61. doi:10.1053/bean.2002.026412751548
  • Jevtović-Todorović V, Todorović SM, Mennerick S, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4:460–463. doi:10.1038/nm0498-4609546794
  • Garakani A, Jaffe RJ, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25:358–369. doi:10.1111/ajad.1237227037733
  • Layzer RB, Fishman RA, Schafer JA. Neuropathy following abuse of nitrous oxide. Neurology. 1978;28(5):504–506. doi:10.1212/WNL.28.5.504205816
  • Blanco G, Peters HA. Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol. 1983;40(7):416–418.6305315
  • Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol. 1998;19:894–896.9613506
  • Mancke F, Kaklauskaitė G, Kollmer J, Weiler M. Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report. Subst Abuse Rehabil. 2016;7:155–159. doi:10.2147/SAR.S11440427729826
  • Sahenk Z, Mendell JR, Couri D, Nachtman J. Polyneuropathy from inhalation of N2O cartridges through a whipped cream dispenser. Neurology. 1978;28:485–487. doi:10.1212/WNL.28.5.485205815
  • Wang L, Fan QJ, Dong MR, et al. Nervous system disorder caused by nitrous oxide intoxication: one case report. Chin J Contemp Neurol Neurosurg. 2016;16:533–537.
  • Shen Q, Lu H, Wang H, Xu Y. Acute cognitive disorder as the initial manifestation of nitrous oxide abusing: a case report. Neurol Sci. 2019. doi:10.1007/s10072-019-04183-w
  • Zheng D, Ba F, Bi G, Guo Y, Gao Y, Li W. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol. 2020;267(2):422–429. doi:10.1007/s00415-019-09600-w31655888
  • Yuan JL, Wang SK, Jiang T, Hu WL. Nitrous oxide induced subacute combined degeneration with longitudinally extensive myelopathy with inverted V-sign on spinal MRI: a case report and literature review. BMC Neurol. 2017;17(1):222. doi:10.1186/s12883-017-0990-329282001
  • Dong X, Ba F, Wang R, Zheng D. Imaging appearance of myelopathy secondary to nitrous oxide abuse: a case report and review of the literature. Int J Neurosci. 2019;129(3):225–229. doi:10.1080/00207454.2018.152680130234413
  • Li XY, Li YY, Jia J, Du P, Feng GD, Jin LR. Nervous system damage caused by laughing gas abuse (with a case report and literature review). Stroke Neurol Dis. 2018;25:59–64.
  • Louis-Ferdinand RT. Myelotoxic, neurotoxic and reproductive adverse effects of nitrous oxide. Adverse Drug React Toxicol Rev. 1994;13:193–206.7734639
  • Myles PS, Leslie K, Chan MT, et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology. 2007;107:221–231. doi:10.1097/01.anes.0000270723.30772.da17667565
  • Leslie K, Myles PS, Chan MT, et al. Nitrous oxide and long-term morbidity and mortality in the ENIGMA trial. Anesth Analg. 2011;112:387–393. doi:10.1213/ANE.0b013e3181f7e2c420861416
  • Rosenberg H, Orkin FK, Springstead J. Abuse of nitrous oxide. Anesth Analg. 1979;58(2):104–106. doi:10.1213/00000539-197903000-00009571232
  • Ng J, O’Grady G, Pettit T, Frith R. Nitrous oxide use in first-year students at Auckland University. Lancet. 2003;361(9366):1349–1350. doi:10.1016/S0140-6736(03)13045-012711474
  • Li HT, Chu CC, Chang KH, et al. Clinical and electrodiagnostic characteristics of nitrous oxide-induced neuropathy in Taiwan. Clin Neurophysiol. 2016;127:3288–3293. doi:10.1016/j.clinph.2016.08.00527567448
  • Lin RJ, Chen HF, Chang YC, Su JJ. Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurol Taiwan. 2011;20:129–137.21739392
  • Cheng HM, Park JH, Hernstadt D. Subacute combined degeneration of the spinal cord following recreational nitrous oxide use. BMJ Case Rep. 2013;2013(mar08 1):bcr2012008509–bcr2012008509. doi:10.1136/bcr-2012-008509
  • Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZM. Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med. 2006;21:1063–1068. doi:10.1111/j.1525-1497.2006.00525.x16970556
  • Savage S, Ma D. The neurotoxicity of nitrous oxide: the facts and “putative” mechanisms. Brain Sci. 2014;4(1):73–90. doi:10.3390/brainsci401007324961701
  • Hathout L, El-Saden S. Nitrous oxide-induced B₁₂ deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B₁₂. J Neurol Sci. 2011;301:1–8. doi:10.1016/j.jns.2010.10.03321112598
  • Morris N, Lynch K, Greenberg SA. Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency. Muscle Nerve. 2015;51:614–616.25297001
  • Hodgkin DC, Karnper J, Mackay M, Pickworth J. Structure of Vitamin B12. Nature. 1956;178:64–66. doi:10.1038/178064a013348621
  • Kräutler B. Vitamin B12: chemistry and biochemistry. Biochem Soc Trans. 2005;33:806–810. doi:10.1042/BST033080616042603
  • Singh SK, Misra UK, Kalita J, Bora HK, Murthy RC. Nitrous oxide related behavioral and histopathological changes may be related to oxidative stress. Neurotoxicology. 2015;48:44–49. doi:10.1016/j.neuro.2015.03.00325766523
  • Veber D, Mutti E, Galmozzi E, et al. Increased levels of the CD40: CD40ligand dyad in the cerebrospinal fluid of rats with vitamin B12 (cobalamin)-deficient central neuropathy. J Neuroimmunol. 2006;176:24–33. doi:10.1016/j.jneuroim.2006.04.00216716410
  • Sotirchos ES, Saidha S, Becker D. Neurological picture. Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI. J Neurol Neurosurg Psychiatry. 2012;83:915–916. doi:10.1136/jnnp-2012-30310522773860
  • Scalabrino G, Nicolini G, Buccellato FR, et al. Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B12 (cobalamin) in the rat central nervous system. FASEB J. 1999;13:2083–2090. doi:10.1096/fasebj.13.14.208310544191
  • Blanco G, Peters HA. Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol. 1983;40:416–418.6305315
  • Kalita J, Chandra S, Bhoi SK, et al. Clinical, nerve conduction and nerve biopsy study in vitamin B12 deficiency neurological syndrome with a short-term follow-up. Nutr Neurosci. 2014;17:156–163. doi:10.1179/1476830513Y.000000007324256995
  • Maze M, Fujinaga M. Recent advances in understanding the actions and toxicity of nitrous oxide. Anaesthesia. 2000;55:311–314. doi:10.1046/j.1365-2044.2000.01463.x10781114
  • Richardson KJ, Shelton KL. N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas. J Pharmacol Exp Ther. 2015;352:156–165. doi:10.1124/jpet.114.21805725368340
  • Tani J, Weng HY, Chen HJ, Chang TS, Sung JY, Lin CS. Elucidating unique axonal dysfunction between nitrous oxide abuse and Vitamin B12 deficiency. Front Neurol. 2019;10:704. doi:10.3389/fneur.2019.0070431354607
  • Stabler SP. Vitamin B12 Deficiency. N Engl J Med. 2013;368(2):149–160. doi:10.1056/NEJMcp111399623301732
  • Scott JM, Dinn JJ, Wilson P, Weir DG. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet. 1981;318(8242):334–337. doi:10.1016/S0140-6736(81)90649-8